Keyphrases
AIDS Clinical Trials
11%
AIDS Dementia Complex
5%
AIDS/HIV
36%
Antiretroviral
5%
Antiretroviral Therapy
27%
Central Nervous System
8%
Cerebrospinal Fluid
29%
Clinical Trials
7%
Cognitive Impairment
6%
Combined Antiretroviral Therapy (cART)
15%
Comorbidity
5%
Confidence Interval
5%
Cultured Hippocampal Neurons
7%
Dementia
5%
Dominantly Inherited Alzheimer's Disease
5%
Efavirenz
8%
Effect Study
7%
Global Deficit Score
6%
Group Studies
7%
Highly Active Antiretroviral Therapy (HAART)
7%
HIV Infection
14%
HIV Neuropathy
12%
HIV Patients
21%
HIV RNA
7%
HIV Viral Load
5%
HIV+
5%
HIV-associated
11%
HIV-associated Neurocognitive Disorders
31%
Human Immunodeficiency Virus Infection
9%
Human Immunodeficiency Virus Type 1 (HIV-1)
10%
Immune Reconstitution
7%
JC Virus
9%
Long-term Potentiation
5%
Multiple Sclerosis
11%
N-methyl-D-aspartate
5%
Natalizumab
11%
Neurocognitive
7%
Neurocognitive Function
5%
Neurocognitive Impairment
11%
Neuropathic Pain
12%
Neuropathy
7%
Odds Ratio
6%
People Living with HIV (PLHIV)
15%
Peripheral Neuropathy
16%
Placebo
7%
Postnatal Rat
7%
Progressive multifocal Leukoencephalopathy
34%
Rat Hippocampal Slices
8%
Risk Factors
5%
Sensory Neuropathy
5%
Neuroscience
Alzheimer's Disease
5%
Blood Plasma
15%
CD4
8%
Central Nervous System
9%
Cognitive Disorders
10%
Efavirenz
7%
HIV Associated Dementia
22%
Human Immunodeficiency Virus
100%
JC Virus
5%
Long-Term Potentiation
5%
Multiple Sclerosis
11%
Natalizumab
11%
Neuropathic Pain
7%
Neuropathy
26%
Placebo
7%
Polyneuropathy
6%
Progressive Multifocal Leukoencephalopathy
21%
Medicine and Dentistry
Alzheimer's Disease
7%
Antiretroviral Therapy
19%
Central Nervous System
9%
Cerebrospinal Fluid
12%
Clinical Trial
9%
Diseases
8%
Highly Active Antiretroviral Therapy
5%
HIV-associated Neurocognitive Disorder
17%
Human Immunodeficiency Virus
59%
Human Immunodeficiency Virus Infection
16%
Infection
6%
Neuropathic Pain
9%
Neuropathy
17%
Placebo
5%
Polyneuropathy
7%
Progressive Multifocal Leukoencephalopathy
18%
Sensory Neuropathy
6%